Loading...

Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells

Trastuzumab has been widely used for the treatment of human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer, however, it cannot easily cross the blood-brain barrier (BBB) and is known to increase the incidence of brain metastases. In contrast, lapatinib has a low molecular wei...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Yu, Tosol, Cho, Bong Jun, Choi, Eun Jung, Park, Ji Min, Kim, Dan Hyo, Kim, In Ah
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346700/
https://ncbi.nlm.nih.gov/pubmed/27738326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12597
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!